Craig T. Basson
Dr. Basson served as chief medical officer, global head of research and development and interim CEO of Boston Pharmaceuticals until mid 2022 when he became an advisor to the board of directors. Previously he was global head of translational medicine for the cardiovascular and metabolic therapeutic areas at the Novartis Institutes for Biomedical Research. He currently i a senior lecturer at Harvard Medical School and an attending physician at Brigham and Women’s Hospital.
- October 2022
Added to: Olatec Therapeutics LLC - New York, NY
Olata Therapeutics is a clinical-stage biopharmaceutical company developing a platform of oral inhibitors to treat and prevent a broad spectrum of acute and chronic inflammatory diseases.